0000899243-23-005547.txt : 20230217
0000899243-23-005547.hdr.sgml : 20230217
20230217192039
ACCESSION NUMBER: 0000899243-23-005547
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230215
FILED AS OF DATE: 20230217
DATE AS OF CHANGE: 20230217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Espinoza Octavio
CENTRAL INDEX KEY: 0001905248
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33093
FILM NUMBER: 23644748
MAIL ADDRESS:
STREET 1: C/O LIGAND PHARMACEUTICALS INC
STREET 2: 3911 SORRENTO VALLEY BOULEVARD, STE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000886163
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770160744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-550-7500
MAIL ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-15
0
0000886163
LIGAND PHARMACEUTICALS INC
LGND
0001905248
Espinoza Octavio
3911 SORRENTO VALLEY BOULEVARD,
SUITE 110
SAN DIEGO
CA
92121
0
1
0
0
Chief Financial Officer
Common Stock
2023-02-15
4
F
0
849
72.98
D
18096
D
Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.
/s/ Andrew Reardon, Attorney-in-Fact for Octavio Espinoza
2023-02-17